Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.
- 16 April 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (8) , 3357-3361
- https://doi.org/10.1073/pnas.93.8.3357
Abstract
Complement receptor 1 (CR1, CD35) and complement receptor 2 (CR2, CD21) have been implicated as regulators of B-cell activation. We explored the role of these receptors in the development of humoral immunity by generating CR1- and CR2-deficient mice using gene-targeting techniques. These mice have normal basal levels of IgM and of IgG isotypes. B- and T-cell development are overtly normal. Nevertheless, B-cell responses to low and high doses of a T-cell-dependent antigen are impaired with decreased titers of antigen-specific IgM and IgG isotypes. This defect is not complete because there is still partial activation of B lymphocytes during the primary immune response, with generation of splenic germinal centers and a detectable, although reduced, secondary antibody response. These data suggest that certain T-dependent antigens manifest an absolute dependence on complement receptors for the initiation of a normally robust immune response.Keywords
This publication has 29 references indexed in Scilit:
- Abnormal B lymphocyte delevopment, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction moleculeImmunity, 1995
- The CD19/CD21 signal transduction complex of B lymphocytesImmunology Today, 1994
- Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in LymphotoxinScience, 1994
- The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytesCurrent Opinion in Immunology, 1993
- The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of functionImmunology Today, 1992
- Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.The Journal of Experimental Medicine, 1992
- Suppression of the Immune Response by a Soluble Complement Receptor of B LymphocytesScience, 1991
- Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.The Journal of Experimental Medicine, 1991
- In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.The Journal of Experimental Medicine, 1990
- Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genesNature, 1988